Pharmacokinetic Study on Budesonide/Formoterol Device-metered Dry Powder Inhalers

Summary

The primary objective of this study is to evaluate the acceptance range with which two Symbicort Turbohaler batches could be declared bioequivalent in a bioequivalence setting. The secondary objective is to compare pharmacokinetic parameters of the reference product batches and Budesonide/formoterol Easyhaler.

Timeline

Start

2012-08

Primary completion

2012-11

Completion

2012-11

Drugs

Indications